{
    "organizations": [],
    "uuid": "74bdaef2061f6b31fa1cc5f18a9667488ae259d8",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-resverlogix-announces-recommendati/brief-resverlogix-announces-recommendation-from-data-safety-monitoring-board-for-study-of-apabetalone-idUSFWN1QG0T5",
    "ord_in_thread": 0,
    "title": "BRIEF-Resverlogix Announces Recommendation From Data Safety Monitoring Board For Study Of Apabetalone",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 26 (Reuters) - Resverlogix Corp:\n* RESVERLOGIX ANNOUNCES SIXTH POSITIVE RECOMMENDATION FROM DATA SAFETY MONITORING BOARD FOR PHASE 3 STUDY OF APABETALONE\n* FULL ENROLLMENT FOR BETONMACE PHASE 3 TRIAL CONTINUES TO BE ANTICIPATED IN FIRST HALF OF 2018 Source text for Eikon: Further company coverage:\n ",
    "published": "2018-02-26T20:12:00.000+02:00",
    "crawled": "2018-02-27T14:40:42.015+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "resverlogix",
        "corp",
        "resverlogix",
        "announces",
        "sixth",
        "positive",
        "recommendation",
        "data",
        "safety",
        "monitoring",
        "board",
        "phase",
        "study",
        "apabetalone",
        "full",
        "enrollment",
        "betonmace",
        "phase",
        "trial",
        "continues",
        "anticipated",
        "first",
        "half",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}